Qiagen N.V. Common Shares (QGEN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Qiagen N.V. Common Shares, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$50.33
+0.32% today
Market cap
$10.3B
Overall quality
—
Kronos AI 30-day
−20.8%
0 of 8 simulated paths end higher
Qiagen N.V. Common Shares (QGEN) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $10.3B. It trades at $50.33, up 0.32% today. 12 analysts' average target of $49.49 implies −1.7% from today's price. Kronos AI's 30-day forecast is −20.8% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $49.49 |
| Low – high | $40.00 – $53.00 |
| Analysts | 12 |
| Upside to average | −1.7% |
Kronos AI 30-day forecast
| Expected close | $39.72 (−20.8%) |
| Likely range | −25.6% … −17.3% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.